Mission Palms Post Acute | |
6461 East Baywood Avenue, Mesa, Arizona 85206 | |
(480) 832-5160 | |
Name | Mission Palms Post Acute |
---|---|
Location | 6461 East Baywood Avenue, Mesa, Arizona |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 160 |
Occupancy Rate | 69.69% |
Medicare ID (CCN) | 035071 |
Legal Business Name | Royal View Healthcare, Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1275581951 |
Organization Name | EVERGREEN AT MESA, L.L.C. |
Doing Business As | EVERGREEN VALLEY HEALTH AND REHABILITATION CENTER |
Address | 6458 E Broadway Rd, Mesa, AZ 85206 |
Phone Number | 480-832-5160 |
News Archive
The American health care landscape has changed significantly in the three decades since the landmark "DeCamp Report" first argued that ethics training should be required for all medical students, yet the fundamental importance of professionalism and ethical practice has only solidified.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
Kaiser Health News provides a fresh take on health policy developments with "Pick-Up Line?" by Joel Pett.
Mortality from coronary heart disease declined in Sweden from 1986 to 2002. The improvement was due mainly to a reduction in risk factors among the healthy population (primary prevention) and, to a lesser extent, treatment of people who already had developed heart disease (secondary prevention).
› Verified 8 days ago
NPI Number | 1366084790 |
Organization Name | ROYAL VIEW HEALTHCARE, INC. |
Address | 6461 E Baywood Ave, Mesa, AZ 85206 |
Phone Number | 480-832-5160 |
News Archive
The American health care landscape has changed significantly in the three decades since the landmark "DeCamp Report" first argued that ethics training should be required for all medical students, yet the fundamental importance of professionalism and ethical practice has only solidified.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
Kaiser Health News provides a fresh take on health policy developments with "Pick-Up Line?" by Joel Pett.
Mortality from coronary heart disease declined in Sweden from 1986 to 2002. The improvement was due mainly to a reduction in risk factors among the healthy population (primary prevention) and, to a lesser extent, treatment of people who already had developed heart disease (secondary prevention).
› Verified 8 days ago
NPI Number | 1366088411 |
Organization Name | ROYAL VIEW HEALTHCARE LLC |
Doing Business As | MISSION PALMS POST ACUTE |
Address | 6461 E Baywood Ave, Mesa, AZ 85206 |
Phone Number | 480-832-5160 |
News Archive
The American health care landscape has changed significantly in the three decades since the landmark "DeCamp Report" first argued that ethics training should be required for all medical students, yet the fundamental importance of professionalism and ethical practice has only solidified.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
Kaiser Health News provides a fresh take on health policy developments with "Pick-Up Line?" by Joel Pett.
Mortality from coronary heart disease declined in Sweden from 1986 to 2002. The improvement was due mainly to a reduction in risk factors among the healthy population (primary prevention) and, to a lesser extent, treatment of people who already had developed heart disease (secondary prevention).
› Verified 8 days ago
NPI Number | 1508037987 |
Organization Name | PINNACLE HEALTH FACILITIES XXVI LP |
Doing Business As | MISSION PALMS OF MESA HEALTH AND REHABILITATION CENTER |
Address | 6461 E Baywood Ave, Mesa, AZ 85206 |
Phone Number | 480-832-5160 |
News Archive
The American health care landscape has changed significantly in the three decades since the landmark "DeCamp Report" first argued that ethics training should be required for all medical students, yet the fundamental importance of professionalism and ethical practice has only solidified.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
Kaiser Health News provides a fresh take on health policy developments with "Pick-Up Line?" by Joel Pett.
Mortality from coronary heart disease declined in Sweden from 1986 to 2002. The improvement was due mainly to a reduction in risk factors among the healthy population (primary prevention) and, to a lesser extent, treatment of people who already had developed heart disease (secondary prevention).
› Verified 8 days ago
NPI Number | 1659925733 |
Organization Name | ROYAL VIEW HEALTHCARE LLC |
Doing Business As | MISSION PALMS POST ACUTE |
Address | 6461 E Baywood Ave, Mesa, AZ 85206 |
Phone Number | 480-832-5160 |
News Archive
The American health care landscape has changed significantly in the three decades since the landmark "DeCamp Report" first argued that ethics training should be required for all medical students, yet the fundamental importance of professionalism and ethical practice has only solidified.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
Kaiser Health News provides a fresh take on health policy developments with "Pick-Up Line?" by Joel Pett.
Mortality from coronary heart disease declined in Sweden from 1986 to 2002. The improvement was due mainly to a reduction in risk factors among the healthy population (primary prevention) and, to a lesser extent, treatment of people who already had developed heart disease (secondary prevention).
› Verified 8 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The American health care landscape has changed significantly in the three decades since the landmark "DeCamp Report" first argued that ethics training should be required for all medical students, yet the fundamental importance of professionalism and ethical practice has only solidified.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
Kaiser Health News provides a fresh take on health policy developments with "Pick-Up Line?" by Joel Pett.
Mortality from coronary heart disease declined in Sweden from 1986 to 2002. The improvement was due mainly to a reduction in risk factors among the healthy population (primary prevention) and, to a lesser extent, treatment of people who already had developed heart disease (secondary prevention).
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 11.55 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.05 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.11 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.92 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.05 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 14.47 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.03 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 87.46 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 12.45 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.12 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.87 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 27.39 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.47 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 11.23 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.01 | 95.98 |
Percentage of short-stay residents who made improvements in function | 73.64 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.41 | 82.93 |
News Archive
The American health care landscape has changed significantly in the three decades since the landmark "DeCamp Report" first argued that ethics training should be required for all medical students, yet the fundamental importance of professionalism and ethical practice has only solidified.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
Kaiser Health News provides a fresh take on health policy developments with "Pick-Up Line?" by Joel Pett.
Mortality from coronary heart disease declined in Sweden from 1986 to 2002. The improvement was due mainly to a reduction in risk factors among the healthy population (primary prevention) and, to a lesser extent, treatment of people who already had developed heart disease (secondary prevention).
› Verified 8 days ago
Mission Palms Post Acute Location: 6461 East Baywood Avenue, Mesa, Arizona 85206 Phone: (480) 832-5160 | |
Montecito Post Acute Care And Rehabilitation Location: 51 South 48th Street, Mesa, Arizona 85206 Phone: (480) 832-8333 | |
Desert Blossom Health & Rehab Center Location: 60 South 58th Street, Mesa, Arizona 85206 Phone: (480) 832-3903 | |
Alta Mesa Health And Rehabilitation Location: 5848 East University Drive, Mesa, Arizona 85205 Phone: (480) 981-0098 |